Pharmacokinetic characterization of amantadine in human brain tissue

Amantadine concentrations in human brain tissue were assessed in order to estimate population pharmacokinetic parameters using the computer program NONMEM. The elimination constant in brain tissue was determined to be 0.00447 [1/h], resulting in a t1/2 of 6.5 days for the mean patient in the populat...

Full description

Saved in:
Bibliographic Details
Published inTherapeutic drug monitoring Vol. 28; no. 5; p. 693
Main Authors Kornhuber, Johannes, Riederer, Peter, Bleich, Stefan, Wiltfang, Jens, Kraus, Thomas, Meineke, Ingolf
Format Journal Article
LanguageEnglish
Published United States 01.10.2006
Subjects
Amantadine - blood
Amantadine - pharmacokinetics
Bayes Theorem
Biological Availability
Brain - metabolism
Half-Life
Humans
Tissue Distribution
Online AccessGet more information

Cover

More Information
Summary:Amantadine concentrations in human brain tissue were assessed in order to estimate population pharmacokinetic parameters using the computer program NONMEM. The elimination constant in brain tissue was determined to be 0.00447 [1/h], resulting in a t1/2 of 6.5 days for the mean patient in the population investigated (n = 19). An estimate of 65.5 L was obtained for the apparent volume of distribution. The elimination half-life of amantadine from brain tissue is much longer than from blood and is comparable to the previously investigated neuroleptic drugs haloperidol and levomepromazine.
ISSN:0163-4356
DOI:10.1097/01.ftd.0000245390.48552.04